Newest VisionWatch Consumer Barometer Shows 6.1 Percent Increase in Vision Care Market Revenues

By Staff
Tuesday, September 1, 2015 9:00 AM ALEXANDRIA, Va.—The latest VisionWatch Consumer Barometer, covering the 12-month period ending June 2015, reflects a 6.1 percent overall increase in revenues for vision care products and services in the U.S. compared to the prior year period.

NEW INVESTORS ‘OPTI-MISTIC’

By Marge Axelrad and John Sailer
Monday, August 31, 2015 12:10 AM Call it ‘Opti-mism.’ The pace of new investment and acquisitions in the retail and optometric side of the U.S. optical business has been intensifying. In 2015, that pace picked up dramatically—and more deals are reportedly on tap for the remainder of this year and into the next—promising to essentially reshape the business in new ways, to realign and restructure the national regional, local optical retail landscape and the presence of vision care in the health care space as well.

NEW INVESTORS ‘OPTI-MISTIC’: A VM Series

By John Sailer
Monday, August 31, 2015 12:09 AM Starting with this issue, VM begins a Special Series exploring the recent influx of private equity capital into the optical business and the multimillion dollar deals (and in one case, billion dollar deal) being made in the sector. With access to record amounts of available money and health care reform encouraging consolidation, this “perfect storm” shows no signs of stopping as mergers and acquisitions continue their pace.

Who's Who and What's What in Investing

By John Sailer
Monday, August 31, 2015 12:08 AM Accredited Investor: Investors who are financially sophisticated with a reduced need for protection, as defined by Regulation D of the Security and Exchange Commission (SEC), these investors can include individuals, banks, insurance companies, employee benefit plans and trusts. Accredited investors must earn $200,000 individually or $300,000 jointly during each of the last two years and expect that to continue; have an individual or net worth of $1 million; and be a general partner, executive officer, director or a related combination.

A Unique Player: Why American Optical Services Lost Its Bet on Optical

By John Sailer
Monday, August 31, 2015 12:06 AM LAS VEGAS—Based in the gambling capital of the U.S., American Optical Services (AOS) lost its bet on consolidation . . . and brought a number of successful optical businesses down with it. Judging from the many successes private equity firms have experienced in the sector, this failure was not due to the market itself, which remains robust, but resulted from poor planning, mismanagement and other factors, according to many of the investors and retailers spoken to by VM.

New Investors, New Thinking, for Optical

By Marge Axelrad
Monday, August 31, 2015 12:00 AM After nearly two years of minimal detail, some tech world P.R. and much discussion, dating back to VM’s own Leadership Summit in 2014, Opternative’s online “eye test,” which they refer to as a “refractive eye exam,” launched in 27 states late last month.

Surgery Partners Files For Initial Public Offering

By Staff
Monday, August 24, 2015 12:23 AM NASHVILLE, Tenn.—Surgery Partners, Inc., a Nashville-based company that operates surgical facilities across the U.S., announced on Aug. 17 that it has filed for a proposed initial public offering of shares of its common stock with the SEC.

InSite Vision Prefers Unsolicited Offer from Multi-National Pharma Company to QLT’s Bid

By Staff
Monday, August 24, 2015 12:22 AM ALAMEDA, Calif.—InSite Vision (OTCBB:INSV), an ophthalmic Pharmaceutical company, announced Friday that its board of directors has determined that the previously announced unsolicited offer from a multi-national pharmaceutical company to acquire InSite for $0.25 per share in an all-cash transaction constitutes a “company superior proposal” compared with InSite’s previously announced definitive agreement with QLT dated (NASDAQ: QLTI) (TSX: QLT) June 8, 2015.

Inotek Pharmaceuticals Corporation Announces Closing of $79.2 Million Public Offering

By Staff
Friday, August 21, 2015 12:23 AM LEXINGTON, Mass.—Inotek Pharmaceuticals Corporation (NASDAQ: ITEK) announced the closing of its previously announced public offering of 5,400,000 shares of its common stock at a public offering price of $12.75 per share before underwriting discounts on Aug. 18, 2015.

InSite Reports Second Quarter 2015 Financial Results

By Staff
Monday, August 17, 2015 12:23 AM ALAMEDA, Calif.—InSite Vision Incorporated (OTCBB: INSV) reported financial results for the quarter ended June 30, 2015.

Vuzix Reports Second Quarter 2015 Operating Results

By Staff
Monday, August 17, 2015 12:22 AM ROCHESTER, N.Y.—Vuzix Corporation (NASDAQ: VUZI), a leading supplier of video eyewear and smart glasses products in the consumer, enterprise and entertainment markets, provided an update on its business initiatives and reported its second quarter financial results for the period ended June 30, 2015.

Spy Inc. Reports Results for Q2 and First Half 2015

By Staff
Wednesday, August 12, 2015 12:26 AM CARLSBAD, Calif.—Spy Inc. (OTCBB: XSPY) has announced their financial results for the second quarter and first half ended June 30, 2015.

InSite Vision Receives Unsolicited Proposal From a Multi-National Pharmaceutical Company

By Staff
Wednesday, August 12, 2015 12:23 AM ALAMEDA, Calif.—InSite Vision Inc. (OTCBB:INSV) today announced that the company has received an unsolicited proposal from a multi-national pharmaceutical company to acquire all outstanding shares of InSite Vision common stock at a price of $0.25 per share in cash.

New Look Vision Group Reports Record High Results for Second Quarter

By Staff
Monday, August 10, 2015 12:23 AM MONTREAL—New Look Vision Group Inc. (TSX: BCI) (formerly New Look Eyewear Inc.) announced record high results for the second quarter ended June 27, 2015.
Loading...